万邦德(002082)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002082 万邦德

已收盘 06-14 15:00:00

{"stockData":{"symbol":"002082","market":"SZ","secType":"STK","nameCN":"万邦德","latestPrice":4.44,"timestamp":1718348631000,"preClose":4.5,"halted":0,"volume":5156200,"delay":0,"floatShares":617000000,"shares":617000000,"eps":0.0823,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.06,"latestTime":"06-14 15:00:00","open":4.51,"high":4.53,"low":4.4,"amount":22960400,"amplitude":0.0289,"askPrice":4.44,"askSize":148,"bidPrice":4.43,"bidSize":163,"shortable":0,"etf":0,"ttmEps":0.0823,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1718587800000},"adr":0,"adjPreClose":4.5,"symbolType":"stock","openAndCloseTimeList":[[1718328600000,1718335800000],[1718341200000,1718348400000]],"highLimit":4.95,"lowLimit":4.05,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":616689055,"pbRate":1.03,"roa":"--","roe":"1.08%","epsLYR":0.08,"committee":-0.18916,"marketValue":2738000000,"floatMarketCap":2738000000,"peRate":53.948967,"changeRate":-0.0133,"turnoverRate":0.0084,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-06-17。"},"requestUrl":"/m/hq/s/002082/","defaultTab":"news","newsList":[{"id":"2439462415","title":"万邦德(002082.SZ)：石杉碱甲治疗新生儿缺氧缺血性脑病适应症获美国FDA孤儿药资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2439462415","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439462415?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:17","pubTimestamp":1716977851,"startTime":"0","endTime":"0","summary":"本次石杉碱甲治疗新生儿缺氧缺血性脑病适应症获得FDA孤儿药资格认定，是继石杉碱甲用于重症肌无力获得FDA孤儿药资格认定，及治疗新生儿缺氧缺血性脑病适应症获得FDA“罕见儿科疾病”药物资格认定后的又一重要进展，本次认定将有助于加快公司药品国际化战略布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1127780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0050","BK0004","002082","BK0239","BK0028"],"gpt_icon":0},{"id":"2437808930","title":"万邦德(002082.SZ)实控人之一赵守明完成增持 累计增持732.69万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2437808930","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437808930?lang=zh_cn&edition=full","pubTime":"2024-05-24 19:06","pubTimestamp":1716548767,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万邦德(002082.SZ)公告，公司实际控制人之一、董事长、总经理赵守明增持股份计划实施完毕，其累计增持公司股份732.69万股，占公司现有总股本的1.1881%，增持金额为3277.98万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1125946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0050","BK0239","BK0028","BK0004","002082"],"gpt_icon":0},{"id":"2434441067","title":"万邦德(002082.SZ)董事长累计增持1.19%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2434441067","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434441067?lang=zh_cn&edition=full","pubTime":"2024-05-09 18:33","pubTimestamp":1715250836,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万邦德(002082.SZ)发布公告，截至2024年5月8日，本次增持计划时间已过半。公司实际控制人之一、董事长、总经理赵守明已通过深圳证券交易所集中竞价交易的方式累计增持公司股份732.69万股，占公司现有总股本的1.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1119402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0004","BK0028","002082","BK0050"],"gpt_icon":0},{"id":"2433713953","title":"万邦德（002082）5月8日主力资金净买入350.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433713953","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433713953?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:21","pubTimestamp":1715152916,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月8日收盘，万邦德报收于5.25元，上涨2.14%，换手率1.47%，成交量9.09万手，成交额4740.38万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：万邦德2024年一季报显示，公司主营收入4.29亿元，同比上升11.41%；归母净利润2883.85万元，同比上升5.49%；扣非净利润1409.73万元，同比下降43.19%；负债率36.73%，投资收益22.86万元，财务费用1115.1万元，毛利率36.17%。万邦德主营业务：医药制造、医疗器械大健康产业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800021286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0050","BK0028","BK0004","002082"],"gpt_icon":0},{"id":"2433622891","title":"万邦德(002082.SZ)：石杉碱甲获美国FDA罕见儿科疾病药物认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2433622891","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433622891?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:23","pubTimestamp":1715070235,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万邦德 发布公告，公司全资子公司万邦德制药集团有限公司于2024年5月1日收到美国食品药品监督管理局的认定函，石杉碱甲用于治疗新生儿缺氧缺血性脑病获得FDA授予的“罕见儿科疾病”药物认定。据悉，新生儿HIE是由脑组织缺氧和脑血流量减少引起的一种新生儿脑损伤疾病，目前治疗方式包括支持疗法、控制惊厥、治疗脑水肿、亚低温治疗等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1118162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0004","BK0239","BK0028","002082","BK0050"],"gpt_icon":0},{"id":"2431102878","title":"图解万邦德一季报：第一季度单季净利润同比增5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431102878","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431102878?lang=zh_cn&edition=full","pubTime":"2024-04-30 02:22","pubTimestamp":1714414954,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦德2024年一季报显示，公司主营收入4.29亿元，同比上升11.41%；归母净利润2883.85万元，同比上升5.49%；扣非净利润1409.73万元，同比下降43.19%；负债率36.73%，投资收益22.86万元，财务费用1115.1万元，毛利率36.17%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000003258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002082"],"gpt_icon":0},{"id":"2431868266","title":"万邦德(002082.SZ)发一季度业绩，净利润2883.85万元，同比增长5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431868266","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431868266?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:23","pubTimestamp":1714397020,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万邦德(002082.SZ)发布2024年第一季度报告，报告期内公司实现营业收入4.29亿元，同比增长11.41%;归属于上市公司股东的净利润2883.85万元，同比增长5.49%;归属于上市公司股东扣除非经常性损益净利润1409.73万元，同比减少43.19%;基本每股收益0.0466元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1115121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002082"],"gpt_icon":0},{"id":"2431725832","title":"万邦德最新公告：一季度净利润2883.85万元 同比增长5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431725832","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431725832?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:20","pubTimestamp":1714389607,"startTime":"0","endTime":"0","summary":"万邦德公布2024年一季度报告，报告期营业收入4.29亿元，同比增长11.41%；归属于上市公司股东的净利润2883.85万元，同比增长5.49%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900026019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002082"],"gpt_icon":0},{"id":"2417261258","title":"万邦德(002082.SZ)实控人赵守明累计增持公司732.69万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2417261258","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417261258?lang=zh_cn&edition=full","pubTime":"2024-03-06 19:40","pubTimestamp":1709725200,"startTime":"0","endTime":"0","summary":"万邦德(002082.SZ)发布公告，截至公告披露日，公司实际控制人之一、董事长、总经理赵守明已通过深圳证券交易所集中竞价交易的方式累计增持公司股份732.69万股，占公司总股本的1.1881%，增持金额为3277.98万元。赵守明及其一致行动人合计持有公司股份50.0653%。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-06/doc-inamkuik9960804.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-06/doc-inamkuik9960804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0050","BK0028","002082","BK0004","BK0239"],"gpt_icon":0},{"id":"2416692212","title":"万邦德(002082.SZ)：化学原料药富马酸丙酚替诺福韦上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2416692212","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416692212?lang=zh_cn&edition=full","pubTime":"2024-03-01 18:24","pubTimestamp":1709288640,"startTime":"0","endTime":"0","summary":"万邦德发布公告，公司全资子公司万邦德制药集团有限公司于近日收到国家药品监督管理局核准签发的富马酸丙酚替诺福韦《化学原料药上市申请批准通知书》。本次获得富马酸丙酚替诺福韦化学原料药上市申请批准通知书，表明该原料药已符合国家相关药品审评技术标准，符合GMP要求后可进行生产销售，进一步丰富公司产品线，对公司经营发展具有一定的积极作用。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-01/doc-inakvksc0249546.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-01/doc-inakvksc0249546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0050","002082","BK0028","BK0004"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2006-11-20","address":"浙江省湖州市吴兴区织里镇栋梁路1688号","stockEarnings":[{"period":"1week","weight":-0.0045},{"period":"1month","weight":-0.1311},{"period":"3month","weight":-0.1173},{"period":"6month","weight":-0.3403},{"period":"1year","weight":-0.372},{"period":"ytd","weight":-0.3063}],"companyName":"万邦德医药控股集团股份有限公司","boardCode":"AI0027","perCapita":"179163股","boardName":"医药制造业","registeredCapital":"61668万元","compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":-0.028},{"period":"3month","weight":-0.0072},{"period":"6month","weight":0.0306},{"period":"1year","weight":-0.0677},{"period":"ytd","weight":0.0194}],"survey":"　　万邦德医药控股集团股份有限公司主营业务为现代中药、化学原料药及化学制剂的研发、生产和销售以及提供高端医疗器械研制、医疗设备服务和提供医院工程服务。主要产品是心脑血管系统主导产品、神经系统主导产品、呼吸系统主导产品、消化系统主导产品、精神系统主导产品、骨科植入器械、医疗设备及医院工程服务、一次性无菌医用高分子耗材、防护用品。","serverTime":1718546123493,"listedPrice":6.36,"stockholders":"30866人(较上一季度减少81.54%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万邦德(002082)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万邦德(002082)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万邦德,002082,万邦德股票,万邦德股票老虎,万邦德股票老虎国际,万邦德行情,万邦德股票行情,万邦德股价,万邦德股市,万邦德股票价格,万邦德股票交易,万邦德股票购买,万邦德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万邦德(002082)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万邦德(002082)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}